Fosamax Femur Fracture Experts Allowed In As 2nd MDL Trial Gets Under Way In N.J.

Fosamax Femur Fracture Experts Allowed In As 2nd MDL Trial Gets Under Way In N.J.

TRENTON, N.J. - Two days into trial, a New Jersey federal judge presiding over the second Fosamax femur fracture trial denied Merck Sharp and Dohme Corp.'s motion to exclude causation testimony by four plaintiff expert witnesses (In Re: Fosamax $(Alendronate Sodium$) Products Liability Litigation, MDL Docket No. 08-md-00008, Bernadette Glynn, et al. v. Merck Sharpe & Dohme Corp., No. 11-5304, D. N.J.).

Find full version on lexis Advance®
Access this news story on lexis.com®